Summary of findings: Comparison 3 ‐ deferiprone (DFP) vs deferasirox (DFX)
SAE (chelation‐related) (n/N)
1 finding from 1 review
- Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia 2023 · Cochrane Headline outcomes only1.54 [0.44, 5.39]1 study · 390 participantsVery low